MedPath

Comparison of outcomes after HLA-haploidentical stem cell transplantation using posttransplantation cyclophosphamide (PTCY) and unrelated allogeneic stem cell transplantation.

Not Applicable
Conditions
Patients receiving HLA haploidentical stem cell transplantation with posttransplantation cyclophosphamide or unrelated stem cell transplantation.
Registration Number
JPRN-UMIN000033198
Lead Sponsor
Hokkaido University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
279
Inclusion Criteria

Not provided

Exclusion Criteria

Not applicable

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath